Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Biocorrx Inc. (BICX) had Cost of Goods Sold of $0.00M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.01M |
|
$-5.11M |
|
|
Cost of Goods Sold |
$0.00M |
$0.01M |
|
$5.13M |
|
$-5.12M |
|
$-0.09M |
|
$-5.21M |
|
$-5.21M |
|
$-5.21M |
|
$-5.21M |
|
$-5.21M |
|
$-5.21M |
|
$-5.12M |
|
$-3.93M |
|
10.46M |
|
10.46M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$0.12M |
|
$0.02M |
|
$0.27M |
|
$0.39M |
|
$8.21M |
|
$4.37M |
|
$4.53M |
|
$12.74M |
|
$-12.38M |
|
$-12.36M |
|
$-12.36M |
|
13.30M |
|
| Cash Flow Statement Financials | |
$-1.10M |
|
-- |
|
$1.12M |
|
$0.07M |
|
$0.09M |
|
$0.02M |
|
$1.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-0.55 |
|
-0.56 |
|
78.25% |
|
-66829.81% |
|
-66829.81% |
|
-51208.01% |
|
-67998.72% |
|
-66616.10% |
|
$-1.10M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
42.11% |
|
42.16% |
|
-1350.49% |
|
65.31% |
|
$-0.93 |
|
$-0.10 |
|
$-0.10 |
|